Recombinant TNFSF4 (Oxelumab Biosimilar) anticorps
Reactivité: Humain
FACS, BR
Hôte: Human
Monoclonal
R4930
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits TNFSF4 (Oxelumab Biosimilar)
- TNFSF4 (Oxelumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Human
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp TNFSF4 (Oxelumab Biosimilar) est non-conjugé
-
Application
- Flow Cytometry (FACS), Blocking Reagent (BR)
- Specificité
- Binds to human OX40L.
- Attributs du produit
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Pureté
- > 98 % as determined by SDS-PAGE
- niveau d'endotoxine
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogène
- Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
- Clone
- R4930
- Isotype
- IgG1 kappa
-
-
- Indications d'application
- This antibody binds to the co-stimulatory OX40L, inhibiting its interaction with OX40.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Antigène
- TNFSF4 (Oxelumab Biosimilar)
- Abstract
- TNFSF4 (Oxelumab Biosimilar) Produits
- Synonymes
- anticorps CD134L, anticorps CD252, anticorps GP34, anticorps OX-40L, anticorps OX4OL, anticorps TXGP1, anticorps TNF superfamily member 4, anticorps TNFSF4
- Classe de substances
- Biosimilar
- Sujet
- CD252, TNFSF4, tumor necrosis factor (TNF) superfamily member 4, OX40 ligand, OX-40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34
- UniProt
- P23510
-
Vous êtes ici:
